Skip to main content

Neonatal Escherichia coli Bloodstream Infections: Clinical Outcomes and Impact of Initial Antibiotic Therapy.

Publication ,  Journal Article
Bergin, SP; Thaden, JT; Ericson, JE; Cross, H; Messina, J; Clark, RH; Fowler, VG; Benjamin, DK; Hornik, CP; Smith, PB ...
Published in: Pediatr Infect Dis J
September 2015

BACKGROUND: Escherichia coli is a common cause of bloodstream infections (BSIs) in infants and is associated with high mortality and morbidity among survivors. The clinical significance of antibiotic resistance and timing of appropriate antimicrobial therapy in this population is poorly understood. METHODS: We identified all infants with E. coli BSIs discharged from 77 neonatal intensive care units managed by the Pediatrix Medical Group in 2012. We used multivariable logistic regression to evaluate the association between 30-day mortality and ampicillin-resistant E. coli BSI, as well as the number of active empiric antimicrobial agents administered, controlling for gestational age, small-for-gestational age status, early-onset versus late-onset BSI, oxygen requirement, ventilator support and inotropic support on the day of the first positive blood culture. RESULTS: We identified 258 episodes of E. coli BSI, including 123 (48%) ampicillin-resistant isolates. Unadjusted 30-day mortality did not significantly differ between infants with ampicillin-resistant versus ampicillin-susceptible E. coli BSI [11 of 123 (9%) vs. 7 of 135 (5%); P = 0.33; adjusted odds ratio = 1.37 (95% confidence interval: 0.39, 4.77)]. Among ampicillin-resistant E. coli BSIs, 30-day mortality was not significantly lower for infants treated with at least one empiric antimicrobial active against ampicillin-resistant E. coli versus infants receiving no active empiric agent [adjusted odds ratio = 1.50 (0.07, 33.6)]. CONCLUSIONS: In this population of infants with E. coli BSI, ampicillin resistance was not associated with significantly increased mortality. Among the subset of infants with ampicillin-resistant E. coli, appropriate empirical antibiotic therapy was not associated with lower mortality.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Pediatr Infect Dis J

DOI

EISSN

1532-0987

Publication Date

September 2015

Volume

34

Issue

9

Start / End Page

933 / 936

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Survival Analysis
  • Pediatrics
  • Male
  • Infant, Newborn
  • Infant
  • Humans
  • Female
  • Escherichia coli Infections
  • Escherichia coli
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bergin, S. P., Thaden, J. T., Ericson, J. E., Cross, H., Messina, J., Clark, R. H., … Antibacterial Resistance Leadership Group, . (2015). Neonatal Escherichia coli Bloodstream Infections: Clinical Outcomes and Impact of Initial Antibiotic Therapy. Pediatr Infect Dis J, 34(9), 933–936. https://doi.org/10.1097/INF.0000000000000769
Bergin, Stephen P., Joshua T. Thaden, Jessica E. Ericson, Heather Cross, Julia Messina, Reese H. Clark, Vance G. Fowler, et al. “Neonatal Escherichia coli Bloodstream Infections: Clinical Outcomes and Impact of Initial Antibiotic Therapy.Pediatr Infect Dis J 34, no. 9 (September 2015): 933–36. https://doi.org/10.1097/INF.0000000000000769.
Bergin SP, Thaden JT, Ericson JE, Cross H, Messina J, Clark RH, et al. Neonatal Escherichia coli Bloodstream Infections: Clinical Outcomes and Impact of Initial Antibiotic Therapy. Pediatr Infect Dis J. 2015 Sep;34(9):933–6.
Bergin, Stephen P., et al. “Neonatal Escherichia coli Bloodstream Infections: Clinical Outcomes and Impact of Initial Antibiotic Therapy.Pediatr Infect Dis J, vol. 34, no. 9, Sept. 2015, pp. 933–36. Pubmed, doi:10.1097/INF.0000000000000769.
Bergin SP, Thaden JT, Ericson JE, Cross H, Messina J, Clark RH, Fowler VG, Benjamin DK, Hornik CP, Smith PB, Antibacterial Resistance Leadership Group. Neonatal Escherichia coli Bloodstream Infections: Clinical Outcomes and Impact of Initial Antibiotic Therapy. Pediatr Infect Dis J. 2015 Sep;34(9):933–936.

Published In

Pediatr Infect Dis J

DOI

EISSN

1532-0987

Publication Date

September 2015

Volume

34

Issue

9

Start / End Page

933 / 936

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Survival Analysis
  • Pediatrics
  • Male
  • Infant, Newborn
  • Infant
  • Humans
  • Female
  • Escherichia coli Infections
  • Escherichia coli